Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Fatigue 2Neoplasms 1Gastrointestinal Neoplasms 1Chronic Pain 1Breast Neoplasms 1Agnosia 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Has results × Acceptance and Commitment Therapy × Clear all
NCT03661840 2025-03-13

Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors

University of Colorado, Denver

Phase NA Completed
50 enrolled 12 charts

Agnosia, Neoplasms, Chronic Pain

NCT03998618 2024-10-10

Telephone Support for Metastatic Breast Cancer Patients

Indiana University

Phase NA Completed
250 enrolled 20 charts
Breast

Breast Neoplasms, Fatigue

NCT04010227 2022-12-22

Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers

Indiana University

Phase NA Completed
84 enrolled 30 charts
Gastrointestinal

Fatigue, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡